Peyronie's Disease in Teenagers

Journal of Sexual Medicine

Volumn 9, Issue 1, 2012, Pages 302-308

  Tal, Raanan ^a   Hall, Matthew S ^a   Alex, Byron ^a   Choi, Judy ^a   Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Clinical Characteristics; Peyronie's Disease; Peyronie's Plaques; Teenagers

Indexed keywords

ALPHA TOCOPHEROL; HEMOGLOBIN A1C; VERAPAMIL;

ADOLESCENT; ADULT; ANXIETY DISORDER; CLINICAL ARTICLE; COITUS; CONTROLLED STUDY; DEFORMITY; DISEASE DURATION; DISTRESS SYNDROME; DOPPLER ECHOCARDIOGRAPHY; HUMAN; MALE; MASTURBATION; MOOD DISORDER; NONCONTIGUOUS PLAQUE; PAIN; PENILE DEFORMITY; PENILE PAIN; PENIS DISEASE; PENIS INJURY; PEYRONIE DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 84855406020     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02502.x     Document Type: Article

References (30)

1. Smith BH. Peyronie's disease. Am J Clin Pathol 1966;45:670-8.
2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001;88:727-30.
3. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350-3.
4. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F. Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001;40:525-30.
5. Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991;146:1007-9.
6. Tal R, Voelzke BB, Land S, Motarjem P, Munarriz R, Goldstein I, Mulhall JP. Vasculogenic erectile dysfunction in teenagers: A 5-year multi-institutional experience. BJU Int 2009;103:646-50.
7. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. J Sex Med 2008;5:1985-90.
8. Benson GS. Peyronie's disease. J Urol 1993;149:1326.
9. Mulhall J, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: Functional and satisfaction outcomes. J Sex Med 2005;2:132-8.
10. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003;15:63-71.
11. Guest JF, Das Gupta R. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics 2002;20:109-17.
12. Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie's disease. J Urol 2006;175:2115-8. discussion 18.
13. Tefekli A, Kandirali E, Erol H, Alp T, Koksal T, Kadioglu A. Peyronie's disease in men under age 40: Characteristics and outcome. Int J Impot Res 2001;13:18-23.
14. Levine LA, Estrada CR, Storm DW, Matkov TG. Peyronie disease in younger men: Characteristics and treatment results. J Androl 2003;24:27-32.
15. Heruti RJ, Swartzon M, Shochat T, Ashkenazi I, Galor S, Justo D. The minority of young adult men with sexual disorders seek medical treatment. J Sex Med 2007;4:1163-6.
16. Tal R, Nabulsi O, Nelson CJ, Mulhall JP. The psychosocial impact of penile reconstructive surgery for congenital penile deviation. J Sex Med 2010;7:121-8.
17. Yachia D, Beyar M, Aridogan IA, Dascalu S. The incidence of congenital penile curvature. J Urol 1993;150:1478-9.
18. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Peyronie's disease. J Sex Med 2004;1:110-5.
19. Kadioglu A, Tefekli A, Usta M, Demirel S, Tellaloglu S. Surgical treatment of Peyronie's disease with incision and venous patch technique. Int J Impot Res 1999;11:75-81.
20. Rehman J, Benet A, Minsky LS, Melman A. Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol 1997;157:1288-91.
21. Porst H. Corporoplasty of congenital and acquired penis deviations. Technic and results in 62 patients. Urologe A 1989;28:168-71.
22. Deveci S, Hopps CV, O'Brien K, Parker M, Guhring P, Mulhall JP. Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med 2007;4:485-90.
23. King R, Juenemann KP, Levinson IP, Stecher VJ, Creanga DL. Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction. Int J Impot Res 2007;19:398-406.
24. Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, Levine L. Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls. J Sex Med 2008;5:1977-84.
25. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Longitudinal differences in psychological outcomes for men with erectile dysfunction: Results from ExCEED. J Sex Med 2006;3:1068-76.
26. Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease. J Sex Med 2008;5:2179-84.
27. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol 1990;144:1376-9.
28. Regier DA, Farmer ME, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: The Epidemiologic Catchment Area study. Acta Psychiatr Scand 1993;88:35-47.
29. Dean J, Hackett GI, Gentile V, Pirozzi-Farina F, Rosen RC, Zhao Y, Warner MR, Beardsworth A. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, open-label, crossover study. J Sex Med 2006;3:650-61.
30. Anonymous. Trends in sexual risk behaviors among high school students-United States 1991-2001. MMWR 2002;51:856-59.